NEOG — NEOGEN CORP

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 711377 ·
Last close
$9.14
Market Cap
$1.99B
52W High
$11.34
52W Low
$8.16
ADV30
2,443,557
Next earnings
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services. This segment sells its products to the milling and grain, meat and poultry, ready-to-eat, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. Its Animal Safety segment provides reagents and test kits for use in immunoassay production, forensic and animal toxicology, and life science research, as well as colorimetric and chemiluminescent substrates; veterinary instruments and disposables; animal care and other products, including digestive aids and nutritional supplements; rodent and insect control products, and disinfectants; and genomics services, such as DNA genotyping, sequencing, and trait analysis for livestock and companion animals. This segment sells its products to companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 211,200,000 99,000,000 -3,300,000 -17,000,000 3,359,000,000 159,900,000 1,256,600,000
Nov 2025 224,691,000 106,684,000 -5,377,000 -15,924,000 3,359,953,000 145,340,000 1,255,465,000
Aug 2025 209,189,000 94,970,000 -16,091,000 36,338,000 3,378,156,000 138,883,000 1,259,507,000
May 2025 225,459,000 92,855,000 -13,254,000 -612,196,000 3,443,836,000 129,004,000 1,372,582,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$69,542,000
Investing CF
$58,571,000
Financing CF
$-101,213,000
CapEx
$-63,436,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-2.81
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-533,000,000
Inventory
$161,700,000
Receivables
$137,100,000
ST Investments
$0
EBIT TTM
$-565,739,000
Pretax Income TTM
$-628,058,000
Interest Exp TTM
$62,319,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$870,561,024
EBITDA
$81,262,000
Free Cash Flow
$19,474,124
Enterprise Value
$2,572,489,984
Total Cash
$159,900,000
Total Debt
$795,100,032
Shares Out
217,673,041
Trailing EPS
$-2.80
Book Value
$9.66
ROE
-25.6%
ROA
-0.6%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
May 2025 894,661,000 -1,676,000 -1,092,044,000 3,443,836,000 1,372,582,000 58,244,000
May 2024 924,222,000 58,663,000 -9,421,000 4,548,833,000 1,404,691,000 35,264,000
May 2023 822,447,000 37,515,000 -22,870,000 4,554,432,000 1,420,215,000 41,028,000
May 2022 527,159,000 58,618,000 48,307,000 992,929,000 105,555,000 68,038,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$0.30

Peers — same industry

TickerNameMarket CapLastDaily %
NTLA Intellia Therapeutics, Inc. $1.76B $12.61
CLDX Celldex Therapeutics, Inc. $2.42B $30.85
NNNN Anbio Biotechnology $1.45B $33.01
ABSI Absci Corp $823.18M $5.28
QDEL QuidelOrtho Corp $817.61M $11.99

News headlines (Yahoo Finance, 1h cache)

Can Neogen Corporation (NEOG) Become One of the Market’s Best Small-Cap Turnarounds?
2026-05-13 09:00 · Yahoo
Is Weaker Sales And Returns Reshaping The Investment Case For Neogen’s (NEOG) Valuation Assumptions?
2026-05-05 13:21 · Yahoo
1 of Wall Street’s Favorite Stock to Target This Week and 2 Facing Challenges
2026-05-02 16:36 · Yahoo
3 Reasons NEOG is Risky and 1 Stock to Buy Instead
2026-04-29 03:08 · Yahoo
Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
2026-04-23 12:45 · Yahoo
5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call
2026-04-16 11:30 · Yahoo
1 Unprofitable Stock on Our Watchlist and 2 Facing Challenges
2026-04-14 09:10 · Yahoo
2 Small-Cap Stocks Worth Investigating and 1 We Avoid
2026-04-13 20:28 · Yahoo
The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News
2026-04-13 02:09 · Yahoo
Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance
2026-04-13 01:11 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.